FAPI PET/MRI scan for myelofibrosis
Part of Blood & lymphatic clinical trials.
This trial tests whether a special type of PET scan (using a tracer called 18F-FAPI) can see myelofibrosis activity better than standard scans. It may help doctors track the disease more accurately without needing extra biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary myelofibrosis or myelofibrosis that started from another blood cancer.
- You are able to perform daily activities with some help (ECOG score 2 or less) and can lie still for a PET scan.
- You have not had any other cancer, autoimmune disease, or chronic active infection in the past year.
- You do not have a current infection, and you are not pregnant or breastfeeding.
- You have not taken steroid medications in the last 2 weeks or G-CSF shots in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI scans to learn more about myelofibrosis and how it behaves in the body. It may help researchers build better ways to measure the disease using imaging, without needing anesthesia.
This study uses a special PET scan called FAPI to help find or monitor solid tumors. It may help doctors see tumors more clearly and guide treatment decisions.
This trial uses two types of PET/CT scans (FDG and FAPI) to better see and track colorectal cancer that has spread to the belly lining (peritoneum). It aims to help doctors choose the best treatment by improving how they detect and monitor the cancer.
This study uses a new type of PET/CT scan with a tracer called 68Ga-FAPI to help diagnose myelofibrosis, see how advanced it is, and check if treatment is working. It may help doctors better understand your condition and plan your care.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
Hear when a new Myelofibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.